Clear milestones to FDA clearance and commercial scale.

From a technology-ready platform to clinical impact

Q1 2026

Product readiness

  • Finalize wearable ultrasound system and disposable patch

  • Complete design verification and manufacturing readiness

Q2 2026

Clinical validation

  • Conduct clinical studies in high-acuity cardiac settings

  • Generate evidence with leading clinical partners

Q4 2026

FDA submission

  • Complete regulatory documentation

  • Submit for FDA clearance

2027

FDA clearance

  • Obtain FDA clearance

  • Launch at selected reference hospitals

  • Begin limited commercial deployment

2027–2028

Commercial scale

  • Expand across ICU, CCU, and post-discharge HF settings

  • Scale toward 10,000 deployed devices

From clinical validation to FDA clearance and commercial scale.